Latest filing published 12 Jan 2018 for Acer Therapeutics Inc., €632k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +51.2%Entry US$421.68 · Close at T+365 US$637.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
TVM Life Science Ventures VI GmbH & Co KG: trading record in brief
TVM Life Science Ventures VI GmbH & Co KG is a declared insider at 3 companies; the most frequent names are Concert Pharmaceuticals, Inc., Acer Therapeutics Inc. and Protara Therapeutics, Inc. In total, 20 filings cover trades dated from 19 February 2014 to 12 December 2017.
The open-market record is one-sided, with 7 purchases worth €6.7M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. 2018 to date brings 3 purchases and no sales.
A typical purchase (the median) is worth €632k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 12 January 2018, reports an open-market purchase of €632k in Acer Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to TVM Life Science Ventures VI GmbH & Co KG
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 62,062 shares@ US$12.0018.6% of flowCommon StockSEC:0001012975-18-000059:0Canonical exit: 12 Mar 2018 (T+90)
- 21,271 shares@ US$12.006.4% of flowCommon StockSEC:0001012975-18-000059:1Canonical exit: 12 Mar 2018 (T+90)
- 250,000 shares@ US$12.0075.0% of flowCommon StockSEC:0001012975-18-000059:2Canonical exit: 12 Mar 2018 (T+90)
- 227,485 sharesCommon StockSEC:0001012975-17-000726:1
- 1,172,709 sharesCommon StockSEC:0001012975-17-000726:2
- 663,782 sharesCommon StockSEC:0001012975-17-000726:0
- 223,410 shares@ US$10.00Common StockSEC:0001104659-14-075070:0Canonical exit: 25 Jan 2015 (T+90)
- 76,590 shares@ US$10.00Common StockSEC:0001104659-14-075070:1Canonical exit: 25 Jan 2015 (T+90)
- 116,511 shares@ US$4.6023Common StockSEC:0001104659-14-075070:4
- 39,932 shares@ US$4.6023Common StockSEC:0001104659-14-075070:5
- 1,107,154 sharesCommon StockSEC:0001104659-14-075070:2
- 379,462 sharesCommon StockSEC:0001104659-14-075070:3
- 192,003 sharesCommon StockSEC:0001209191-14-012093:4
- 51,045 sharesCommon StockSEC:0001209191-14-012093:5
- 66,287 shares@ US$14.00Common StockSEC:0001209191-14-012093:6Canonical exit: 20 May 2014 (T+90)
- 22,713 shares@ US$14.00Common StockSEC:0001209191-14-012093:7Canonical exit: 20 May 2014 (T+90)
- 289,991 sharesCommon StockSEC:0001209191-14-012093:0
- 560,211 sharesCommon StockSEC:0001209191-14-012093:1
- 148,936 sharesCommon StockSEC:0001209191-14-012093:2
- 99,389 sharesCommon StockSEC:0001209191-14-012093:3
20 of 20 declarations
